NCT04418934View on ClinicalTrials.gov

Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leukoreduced Red Blood Cells

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 1, 2020

Primary Completion Date

May 1, 2021

Study Completion Date

May 1, 2021

Conditions
Whole Blood Donations and Leukoreduction
Interventions
DEVICE

Hemanext One

Leukoreduced red blood cell product from donors in the Investigational Product arm will be processed in the Hemanext Oxygen Reduction Bag for 3 hours and then transferred to the Hemanext Storage Bag and stored for 56 days at 1-6°C.

Trial Locations (2)

23510

American Red Cross Mid-Atlantic Research Facility, Norfolk

45267-0055

Hoxworth Blood Center, University of Cincinnati, Cincinnati

Sponsors

Lead Sponsor

Hemanext
All Listed Sponsors
lead

Hemanext

INDUSTRY

NCT04418934 - Clinical Investigation to Evaluate the Hemanext® Red Blood Cell Processing System for Extended Storage of Leukoreduced Red Blood Cells | Biotech Hunter | Biotech Hunter